Evaluation of newer anti-emetic drugs in prophylaxis of chemotherapy induced nausea and vomiting in cancer patients
Akanksha prajapati
Date : 2019-06-15
Views : 414
Download : 203
Abstract
Dolasetron is a second generation 5-HT3 receptor antagonist administration in as a single intravenous (IV) dose for the prevention of acute and delayed nausea and vomiting associated with i...
